Transcept Pharmaceuticals

About:

Transcept Pharmaceuticals focuses on the development of proprietary products that address therapeutic needs in the field of neuroscience.

Website: http://www.transoral.com

Top Investors: Hercules Capital, Sofinnova Investments, New Enterprise Associates, Vivo Capital, InterWest Partners

Description:

Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.